Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by toinv261on Jun 13, 2014 4:24pm
201 Views
Post# 22659201

Management survey update and thoughts

Management survey update and thoughtsHi folks.

Lots of new posts on Stockhouse and names that I haven't seen before although I have not followed this site for all that long.

Management Survey.
  1. At is stage we have 21 responses. I'm a bit surprised because I was worried that the survey system I chose would not have the capacity to handle all of the responses, but we've got lots of room for more responses so please send in you perceptions to https://www.surveymonkey.com/s/79NWLRH
  2. I glanced at the aliases and names and they are quite different from the normal posters on this site. These names of course will not be revealed as the survey is confidential.
  3. I'm going to close off the study on Monday unless other posters would like it kept open. Please let me know.

Reflections on the Week.
  1. My thoughts on the private placement remain positive.
  2. From what I see Don is now invested for about $900,000 +/- whatever.
  3. I can't recall anything re Dr Wong and it would be good if he had his own cash in because he is the ultimate insider.
  4. I haven't been able to understand the numbers gap that some people have been posting and I'm not going to worry about it.
  5. The key to me is that Don and NGN are in wiith their own money. This, IMO, says that rvx-208 is believed in and on target.
  6. Therefore, in my personal opinion, I think they did the financing to keep the momentum rolling while they play hardball with the next suitor.
  7. The next suitor does not have to be BP. It can be any one of the pharma VCs that want to tap into the huge potential quick return they can achieve by playing the interim step of phase 2c and then flipping to BP at phase 3.
  8. These VCs could also opt for the long term through 30 years of high margin royalties.
  9. I think NGN senses this and perhaps Blackburn as well.

AND YET
  1. There is not a deal at this stage that I am aware of. 
  2. It has been a long time.
  3. Post hoc analysis has been extremely positive...MACE, plaque regression, diabetes, Alheimers, etc. It is almost as if this compound could be the next Aspirin.
  4. The continued support of Eastern and NGN gives me confidence.

So, in summary, I've been in this stock for at least 6 years. I've lost a ton of money on it and I have no intention of selling. This, I believe, will be huge. PMW

IMHO  DYODD
Cheers
Toinv

Bullboard Posts